Brand Name: Retevmo. Generic Name: (selpercatinib). It is used to treat non-small cell lung cancer and thyroid cancer.
RETEVMO (reh-TEHV-moh) is used to treat certain cancers caused by abnormal RET genes in: adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread.
| Brand Name: | Retevmo |
| Generic Name: | selpercatinib |
| Strength: | • Capsules: 40 mg, 80 mg |
| Manufacturer: | Eli Lilly and Company |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “Retevmo (selpercatinib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
